ClinicalTrials.gg
CompletedNCT07921043Updated Nov 6, 2026

Combined Effects of Novel Exercise and Stretching Exercise in Pregnant Females With Restless Leg Syndrome

An interventional study of stretching and novel exercises and novel exercises in Restless Leg Syndrome, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Sep 2025, registered Nov 2026).
Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Restless leg syndrome is a sensorimotor condition .It usually affects more women than in males. Typically the symptoms arise during periods of inactivity and improve with movement. It is assumed to be related to hormonal changes that occur during pregnancy, occurs during 3rd trimester of pregnant female. Progressive muscle relaxation exercise reduces the severity of RLS symptoms and enhances the sleep and quality of life. The aim of this study is to determine the combined effects of novel exercise and stretching exercise on Sleep, Quality of Life and pain in pregnant females with restless leg syndrome.

The study will be randomized control trial and will be conducted in Bashir medical complex and Shahdeen hospital Gujranwala. Non-probability convenience sampling technique will be used and 44 participants of pregnant females will be recruited in study after It will be a single-blinded study in which the assessor will be blinded and will assess the patients and measure the outcomes. Data will be collected from pregnant women aged between 18 and 40 years, with a gestational period of 27 to 34 weeks, who are clinically diagnosed with Restless Leg Syndrome. Participants will be randomly assigned into two groups: Group A (Experimental), which combines Stretching Exercise and Novel Exercise. Group B (Control group) only Perform Novel Exercise Each exercise of the Duration is 8 weeks ,Frequency: 3-5 sessions per week (30-45 minutes/session)The baseline treatment included Myofascial Massage, Thermotherapy, Compressive socks, Acupuncture Participants were advised to apply hot and cold water to their legs before bedtime for seven days. Apply compression stockings when they got up in the morning for 3 weeks and took them off at bedtime. Massage and acupressure reduced the severity of restless legs syndrome The subjects will be divided into two groups.

Read the detailed description

. Group A (Experimental group) Perform combine stretching exercise and novel exercise on each 22 pregnant women with restless leg syndrome Stretching exercises are calf muscle stretch, hamstring stretch and quadriceps stretch front thigh, hip flexor stretches, and ankle rotations. The duration of each stretch is 20 to 30 seconds holds repetition two to three times per session. Each session performs at least 15 to 20 minutes. Repetition 10 times more and other hand Novel exercise includes Ankle Pronation and supination, Calf Raises, Leg lifts, ankle pumps, quadriceps exercise, wall squat etc. Duration of exercise Includes both stretching and novel exercises (each 15-20 minutes) three days per week. Group B (Control group) perform Novel exercise on each 22 pregnant women. The tool will be used for restless leg syndrome, sleep, quality of life is RLS intensity Scale, Numeric Pain rating scale, SF-12 Quality of life. Data will be analyzed by IBMM SPSS version 25.

02

Conditions studied

  • Restless Leg Syndrome

Keywords

  • pregnant females
  • restless leg syndrome
  • novel exercises
03

In context

Restless Legs Syndrome

259 studies on the registry are indexed under Restless Legs Syndrome; 38 are open to participants now.

This study's enrollment of 44 is below the median of 53 across 200 interventional studies indexed under Restless Legs Syndrome.

Browse Restless Legs Syndrome studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

The following rules will be followed for the inclusion of participants in the study:

  • Pregnant females between the age of 20 to 40
  • Patients who were diagnosed with RLS
  • Gestational Period 27 to 34 weeks of Pregnancy

Exclusion criteria

Exclusion Criteria:

The following rules will exclude some patients from this study:

  • Neurological condition like Stroke, Dementia
  • Have a high-risk pregnancy and chronic disease (heart disease, hypertension, thyroid diseases, diabetes mellitus, kidney disease, multiple pregnancy, psychiatric disorders, etc.)
  • Psychological issues
  • Have varicose veins in lower extremities.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    group A

    COMBINE stretching exercises and novel exercises

    Other: stretching and novel exercises

  • Active comparator
    GROUP B

    novel exercises

    Other: novel exercises

Interventions

  • Otherstretching and novel exercises

    Perform combine stretching exercise and novel exercise on each 22 pregnant women with restless leg syndrome Stretching exercises are calf muscle stretch, hamstring stretch and quadriceps stretch front thigh, hip flexor stretches, and ankle rotations. The duration of each stretch is 20 to 30 seconds holds repetition two to three times per session. Each session performs at least 15 to 20 minutes. Repetition 10 times more and other hand Novel exercise includes Ankle Pronation and supination, Calf Raises, Leg lifts, ankle pumps, quadriceps exercise, wall squat etc. Duration of exercise Includes both stretching and novel exercises (each 15-20 minutes) three days per week.

  • Othernovel exercises

    Novel exercise on each 22 pregnant women. The tool will be used for restless leg syndrome, sleep, quality of life is RLS intensity Scale, Numeric Pain rating scale, SF-12 Quality of life.

06

What researchers measure

Primary outcomes

  1. NUMERIC PAIN RATING SCALE

    This tool is used to measure the pain intensity in individuals. It has eleven-point numeric scale ranges from zero to ten. If zero is no pain, then ten is severe pain. It has four levels to assess the pain quality: 0 is considered as no pain, one to 3 is considered as minor pain, four to six is moderate pain, and seven to 10 is considered as severe pain

    Time frame: 6 weeks

Secondary outcomes

  1. QUALITY OF LIFE SCALE -SHORT FORM-12

    SF-12 has 12 different items composed of eight separate headings consisting of subdivisions such as limitations related to physical restrictions, physical performance, ache vitality, emotional issues difficulty, social performance and mental wellness. It has two scores: the physical component summary score (PCS12) and the mental component summary score (MCS12. include general health physical functioning role physical and pain.

    Time frame: 6 weeks

  2. GRONINGEN SLEEP QUALITY SCALE

    The Participant sleep routines and general quality of sleep are evaluated by using this measure. It has fifteen items with true or false values. All true things received one point, with the expectation of items eight, ten,\& twelve which had scores that were inverted .This scale scoring method is scores ranges from zero to fourteen 14 with the first question not being part of final value. It has three categories were created based on the total value normal refreshing sleep (score 0 to 2), slightly disturbed sleep" (value 3-9), \& poor quality of Sleep (10 to 14) significance

    Time frame: 6 weeks

  3. RESTLESS LEG SYNDROME RATING SCALE

    It is a gold standard Scale. Each have ten questions on the test has a grade ranging from 0 to 4. The last five questions evaluate how affects the RLS on daily living activities or quality of life, while the first five questions should concentrate on the intensity of symptoms. The severity of disease is reflected in the total score. 40 are the highest possible score. Mild (1-10), moderate (11-20), severe (21-30), and extremely severe (31-40) are the total RLS severity scores significance

    Time frame: 6 weeks

07

Study locations

1 site
  • Bashir Medical Complex and Shahdeen Hospital
    Chak One Hundred Seventy-five Nine Left, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Feb 2026, 4 months.

Of 46 non-industry interventional studies with no phase under Restless Legs Syndrome, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 42. This study's 4 months is below that.

Counting every sponsor, half of 53 studies reached it within 12 months; a quarter within 5 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2026
First posted
Nov 6, 2026
StartActual
Sep 2, 2025
Primary completionActual
Feb 1, 2026
CompletionActual
Jun 30, 2026
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07921043
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Sep 2, 2025
Primary completion
Feb 1, 2026
Completion
Jun 30, 2026
Last update
Nov 6, 2026

Study contacts

MASOOMA SALEEM, MS WHPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion